Sala M, Pascual S, Rota Roca MR, Matilla AM, Campos M, Delgado M, Ferrer MT, Montero JL, González-Santiago JM, Guerrero A, Aracil C, Rodríguez-Lope C, Romero-Gutiérrez M, Sogbe M, Vázquez-Rodríguez S, Olmo JF, Mínguez B, Cortés-García L, Vallejo-Senra N, Unceta PR, Clos A, Díaz-Bethencourt D, Sánchez AG, Castro RQ, Bustamante J, Perelló C, Urquijo Ponce JJ, Serra HA, Llamoza-Torres CJ, Montoliu S, Fernández-Marcos C, Guiberteau A, Hernández-Guerra M, Vergara M, Fernández-López AM, Valer López-Fando MP, Gutiérrez-García ML, Hernáez-Alsina T, Coll S, Cuyás B, Morillas MJ, Olmedo SR, Fernández-Bermejo M, Roget M, Ramos IC, Pacheco Del Río G, Rifà R, Gacho PC, Barrio ML, Gómez-Rubio M, Peñas I, Serra I, Cachero A, Reig M, Giraldez Á, Guerrero M, Segarra JX, Lledó JL, Díaz-González Á, Delgado C, Iñarrairaegui M, Rodríguez-González MM, Lázaro M, Bermúdez-Ramos M, Lué A, Molina E, Macías-Rodríguez MA, Rodríguez M, Chiminazzo V, Varela M
Bosch-Barrera J, Estévez-García P, Martín-Martorell P, Sabatier R, Nadal E, Sais E, Gascón P, Oaknin A, Rodon J, Lizcano JM, Muñoz-Guardiola P, Fierro-Durán G, Pedrós-Gámez O, Pérez-Montoyo H, Yeste-Velasco M, Cortal M, Pérez-Campos A, Alfón J, Domènech C, Morán T
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer.
Espín, R, Medina-Jover, F, Sigüenza-Andrade, J, Farran-Matas, S, Mateo, FSigüenza, Figueras, A, Sanz, RT, Vicent, GP, Shabbir, A, Ruiz-Auladell, L, Racionero-Andrés, E, García, I, Baiges, A, Franco-Luzón, L, Martínez-Tebar, A, Pardo-Cea, MA, Martínez-Iniesta, M, Wang, XC, Cuyàs, E, Menendez, JA, Lopez-Cerda, M, Muñoz, P, Richaud, I, Raya, A, Fabregat, I, Villanueva, A, Serrat, X, Cerón, J, Alemany, M, Guix, I, Herencia-Ropero, A, Serra, V, Krishnan, R, Mekhail, K, Hakem, R, Bruna, J, Barcellos-Hoff, MH, Viñals, F, Aytes, A, Pujana, MA
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment
González-Guerrero L, Castellet H, Martínez C, González N, Guijarro F, Lloveras N, Pratcorona M, Gich I, Berenguer-Molins P, Perera-Bel J, Zamora L, Mascaró M, Sampol A, Garcia-Guiñón A, Vives S, Tormo M, Arnan M, Villamor N, Nomdedéu JF
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.
Oñate G, Garrido A, Arnan M, Pomares H, Alonso E, Tormo M, Diaz-Beya M, Vives S, Zamora L, Sampol A, Coll R, Salamero O, Cervera M, Garcia A, Vall-Llovera F, Garcia-Avila S, Bargay J, Ortin X, Iranzo E, Guijarro F, Pratcorona M, Nomdedeu JF, Esteve J, Sierra J
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Dierssen-Sotos T, Gómez-Acebo I, Alonso-Molero J, Pérez-Gómez B, Guevara M, Amiano P, Castaño-Vinyals G, Marcos-Delgado A, Mirones M, Obón-Santacana M, Fernández-Tardón G, Molina-Barceló A, Bayo J, Sanvisens A, Fernández-Ortiz M, Fernández-Villa T, Espinosa A, Aizpurua A, Ardanaz E, Aragonés N, Kogevinas M, Pollán M, Llorca J
The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer.
López, J, Llop-Hernández, A, Verdura, S, Serrano-Hervás, E, Martinez-Balibrea, E, Bosch-Barrera, J, Teixidor, E, López-Bonet, E, Martin-Castillo, B, Sardanyés, J, Alarcón, T, Lupu, R, Cuyàs, E, Menendez, JA
Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies
Slomovitz BM, Cibula D, Lv W, Ortaç F, Hietanen S, Backes F, Kikuchi A, Lorusso D, Danska-Bidzinska A, Samouëlian V, Barretina-Ginesta MP, Vulsteke C, Lai CH, Pothuri B, Zhang Y, Magallanes-Maciel M, Amit A, Guarneri V, Zagouri F, Bell M, Welz J, Eminowicz G, Hruda M, J Willmott L, Lichfield J, Wang W, Orlowski R, Aktan G, Gladieff L, Van Gorp T
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.
Ramírez MJ, Pujol R, Minguillón J, Bogliolo M, Persico I, Cavero D, de la Cal A, Río P, Navarro S, Casado JA, Bailador A, de la Fuente AS, de Heredia ML, Almazán F, Antelo ML, Argilés B, Badell I, Baragaño M, Beléndez C, Bermúdez M, Bernués M, Buedo MI, Carrasco E, Català A, Costa D, Cuesta I, Fernandez-Delgado R, Fernández-Teijeiro A, Figuera Á, García M, Gondra A, González M, Muñiz SG, Hernández-Rodríguez I, Ibañez F, Kelleher NJ, Lendínez F, López M, López-Almaraz R, Marchante I, Mendoza C, Nieto J, Ojeda E, Payán-Pernía S, Peláez I, de Soto IP, Portugal R, Ramos-Arroyo MA, Regueiro A, Rodríguez A, Rosell J, Saez R, Sánchez J, Sánchez M, Senent M, Tapia M, Trujillo-Quintero JP, Vagace JM, Verdú-Amorós J, Verdugo V, Vidales I, Villarreal J, Díaz-de-Heredia C, Sevilla J, Bueren JA, Surrallés J
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.
Manubens A, Paiva B, Gutiérrez NC, Fernandez M, Calasanz MJ, Rosiñol L, Oriol A, Blanchard MJ, Carrillo E, Benavente C, Martínez-López J, Bargay J, Hernández MT, de la Rubia J, González Y, Paricio M, de Arriba F, Ocio EM, Teruel AI, de la Guia AL, Sirvent M, Gironella M, Sampol A, Arguiñano JM, Cabrera C, Alegre A, Granell M, Cabañas V, Núñez-Córdoba JM, Mateos MV, Lahuerta JJ, San Miguel JF, Bladé J, Rodriguez-Otero P
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy.
Minty M, Germain A, Sun J, Kaglan G, Servant F, Lelouvier B, Misselis E, Neagoe RM, Rossella M, Cardellini M, Burcelin R, Federici M, Fernandez-Real JM, Blasco-Baque V
Identifying the location-dependent adipose tissue bacterial DNA signatures in obese patients that predict body weight loss.
